Dunlop (Beijing) Medical Equipment Co., Ltd. was founded in 1999, mainly engaged in the coronal artery interventional medical device R & D, production and sales. Is the high-end medical devices can be formed with the strong competition of foreign products relatively small number of companies.
Since its inception, the Dunlop company have completed a stent, catheter and many involved in medical research and development of core products and industrialization, the first in the industry, the State Food and Drug Administration issued a "coronary stent delivery system," Product Registration Certificate (III class).

Our main products include devices for endovascular treatment of coronary heart disease drugs (rapamycin)-eluting stent system , coronary stent delivery system, PTCA balloon catheters, central venous catheters and other drugs. Shape of the company's Shanghai subsidiary to the main product patent ductus arteriosus (PDA) occluder, atrial septal defect (ASD) closure device, ventricular septal defect (VSD) occluder, etc.; world and co-owned subsidiary of the main products class involved in medical products for anesthesia, cardiac interventional procedures with sheath and guide wire, etc.; owned subsidiary of Guardian Golden Sail main products for the treatment of heart disease, angiography machine WINMEDIC 2000.

As of June 2010, Dunlop's from the original six employees has grown to more than 800 employees, including drugs, materials engineering, electrical engineering, precision machining, medical engineering and other professional and technical personnel more than 100 people. Been identified as the "Beijing High-tech Enterprise", "Zhongguancun Science Park, one hundred
innovative technology pilot enterprises", "Beijing municipal enterprise technological centers," was named "2006 Most new materials industry growth enterprise ", and China's Medical Device Industry Association Professional Committee executive director of surgical implants, in January 2009, Dunlop was" Forbes "the Chinese version as the" 2009 China's potential business, "third; March 2009 , was named "outstanding contribution to the 20th anniversary of Zhongguancun business unit"; June 2009, Dunlop won the "Beijing Famous Brand", October 2009, the company was successful domestic A-share listed on GEM; 2010, Dunlop was selected as "Ten Facing Enterprise" and "G20 project."

company is headquartered in Beijing Zhongguancun Science Park Changping Park, the marketing center is located in Central Plaza Beijing West now has a production 11,300 square meters with a clean room, with advanced production and testing equipment and instruments more than 1,000 units, has begun to take shape into the domestic industrial base. In 2007, Dunlop became the first Food and Drug Administration implemented through the national "medical device manufacturers quality management system standards" (GMP) pilot of Review of the stent system manufacturer.

As of August 2010, popular music has its subsidiary 50 utility model patents, the middle of the application 45 patents in technological innovation, the transformation of the industry to go in front.
Music & Poor's will rely on existing technology, and industrial base, accelerating frame, closure devices, catheters and other interventional medical guide wire core product scale, series, and the supporting technology, sought to fight the medical Dunlop leading, world-class "